DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Compositions and methods for inducing HIV-1 antibodies

Abstract

In certain aspects the invention provides HIV-1 immunogens, including envelopes (CH0848) and selections there—from, and methods for swarm immunizations using combinations of HIV-1 envelopes.

Inventors:
; ; ; ;
Issue Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1892604
Patent Number(s):
11246920
Application Number:
16/081,771
Assignee:
Duke University (Durham, NC); Triad National Security, LLC (Los Alamos, NM)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
DOE Contract Number:  
AC52-06NA25396
Resource Type:
Patent
Resource Relation:
Patent File Date: 03/03/2017
Country of Publication:
United States
Language:
English

Citation Formats

Haynes, Barton F., Bonsignori, Mattia, Korber, Bette T., Hraber, Peter T., and Saunders, Kevin. Compositions and methods for inducing HIV-1 antibodies. United States: N. p., 2022. Web.
Haynes, Barton F., Bonsignori, Mattia, Korber, Bette T., Hraber, Peter T., & Saunders, Kevin. Compositions and methods for inducing HIV-1 antibodies. United States.
Haynes, Barton F., Bonsignori, Mattia, Korber, Bette T., Hraber, Peter T., and Saunders, Kevin. Tue . "Compositions and methods for inducing HIV-1 antibodies". United States. https://www.osti.gov/servlets/purl/1892604.
@article{osti_1892604,
title = {Compositions and methods for inducing HIV-1 antibodies},
author = {Haynes, Barton F. and Bonsignori, Mattia and Korber, Bette T. and Hraber, Peter T. and Saunders, Kevin},
abstractNote = {In certain aspects the invention provides HIV-1 immunogens, including envelopes (CH0848) and selections there—from, and methods for swarm immunizations using combinations of HIV-1 envelopes.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue Feb 15 00:00:00 EST 2022},
month = {Tue Feb 15 00:00:00 EST 2022}
}

Works referenced in this record:

Structure and immune recognition of trimeric pre-fusion HIV-1 Env
journal, October 2014


Trimer Stabilizing HIV Envelope Protein Mutations
patent-application, March 2018


Soluble Stabilized Trimeric HIV Env Proteins and Uses Thereof
patent-application, March 2011


Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors
journal, October 2013


Atomic structure of the ectodomain from HIV-1 gp41
journal, May 1997


B cells extract and present immobilized antigen: implications for affinity discrimination
journal, February 2000


Issues in searching molecular sequence databases
journal, February 1994


Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage
journal, January 1990


Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer
journal, February 2017


Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
journal, December 2015


HIV-1 vaccine design through minimizing envelope metastability
journal, November 2018


Structure and Dynamics of the Native HIV-1 Env Trimer
journal, March 2015


Immunoglobulin Gene Insertions and Deletions in the Affinity Maturation of HIV-1 Broadly Reactive Neutralizing Antibodies
journal, September 2014


Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal Sites
journal, July 2007


Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET
journal, April 2019


Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes
journal, December 2015


AFP-specific immunotherapy impairs growth of autochthonous hepatocellular carcinoma in mice
journal, January 2011


Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
journal, December 2013


Single-molecule imaging of non-equilibrium molecular ensembles on the millisecond timescale
journal, February 2016


Co-evolution of HIV Envelope and Apex-Targeting Neutralizing Antibody Lineage Provides Benchmarks for Vaccine Design
journal, June 2018


Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
journal, October 2018


Automated structure refinement of macromolecular assemblies from cryo-EM maps using Rosetta
journal, September 2016


Basic local alignment search tool
journal, October 1990


Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein
journal, March 2016


CLUSTAL: a package for performing multiple sequence alignment on a microcomputer
journal, December 1988


Novel HIV-1 Envelope Glycoprotein
patent-application, October 2011


Advanced ensemble modelling of flexible macromolecules using X-ray solution scattering
journal, February 2015


Features and development of Coot
journal, March 2010


Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
journal, April 1988


Monitoring and interpreting the intrinsic features of somatic hypermutation
journal, April 1998


Purification and purity assessment of RNA molecules synthesized with modified nucleosides
patent-application, November 2017


Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action: BMS-626529, Proposed Mechanism of Action
journal, December 2014


Antibodies VRC01 and 10E8 Neutralize HIV-1 with High Breadth and Potency Even with Ig-Framework Regions Substantially Reverted to Germline
journal, January 2014


Method of inducing the production of protective anti-HIV-1 antibodies
patent-application, September 2016


Recombinant HIV-1 Envelope Proteins and Their Use
patent-application, August 2017


Presenting native-like HIV-1 envelope trimers on ferritin nanoparticles improves their immunogenicity
journal, September 2015


Passenger transgenes reveal intrinsic specificity of the antibody hypermutation mechanism: clustering, polarity, and specific hot spots.
journal, March 1993


Generation of Mucosal Anti-Human Immunodeficiency Virus Type 1 T-Cell Responses by Recombinant Mycobacterium smegmatis
journal, November 2006


Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
journal, April 2015


HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant
journal, June 2016


Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
journal, November 2011


Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides
patent-application, February 2016


A Highly Conserved gp120 Inner Domain Residue Modulates Env Conformation and Trimer Stability
journal, October 2016


Molecular Mechanisms of Antibody Somatic Hypermutation
journal, June 2007


Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
journal, October 2010


Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
journal, November 2009


Oligomeric Structure of the Human Immunodeficiency Virus Type 1 Envelope Protein on the Virion Surface
journal, August 2002


Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization
journal, August 2017


EMRinger: side chain–directed model and map validation for 3D cryo-electron microscopy
journal, August 2015


Crystal structures of trimeric HIV envelope with entry inhibitors BMS-378806 and BMS-626529
journal, August 2017


Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
journal, June 1998


Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
journal, May 2016


Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site
journal, September 2016


Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV
journal, July 2018


Polyvalent immunogen
patent-application, August 2003


Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
journal, March 2016


Promiscuous Glycan Site Recognition by Antibodies to the High-Mannose Patch of gp120 Broadens Neutralization of HIV
journal, May 2014


Structural basis of coreceptor recognition by HIV-1 envelope spike
journal, December 2018


RNA Containing Modified Nucleosides and Methods of Use Thereof
patent-application, October 2013


Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system
journal, August 2012


Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120
journal, June 2012


Improved tools for biological sequence comparison.
journal, April 1988


Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection
journal, January 2014


RNA Containing Modified Nucleosides and Methods of Use Thereof
patent-application, May 2013


CATNAP: a tool to compile, analyze and tally neutralizing antibody panels
journal, June 2015


Role of HIV membrane in neutralization by two broadly neutralizing antibodies
journal, November 2009


Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
journal, December 2009


Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens
patent, May 2011


Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes
journal, November 2015


Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1
journal, July 2014


Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
journal, July 2010


Developing an HIV vaccine
journal, March 2017


Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer
journal, June 2017


Modified GP140 Envelope Polypeptides of HIV-1 Isolates, Compositions, Stabilized Trimeric Complexes, and Uses Thereof
patent-application, October 2011


Adjuvants for human vaccines
journal, June 2012


Broadly Neutralizing Antibody 8ANC195 Recognizes Closed and Open States of HIV-1 Env
journal, September 2015


Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies
journal, July 2014


RNA Containing Modified Nucleosides and Methods of Use Thereof
patent-application, February 2017


HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
journal, September 2016


Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
journal, June 2016


Molecular architecture of native HIV-1 gp120 trimers
journal, July 2008


Uncleaved prefusion-optimized gp140 trimers derived from analysis of HIV-1 envelope metastability
journal, June 2016


Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility
journal, December 2009


Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
journal, March 2018


RNA Containing Modified Nucleosides and Methods of Use Thereof
patent-application, February 2015


Antibody Binding Is a Dominant Determinant of the Efficiency of Human Immunodeficiency Virus Type 1 Neutralization
journal, November 2006


Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection
journal, April 2015


Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
journal, March 2016


Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions
journal, October 2014


Human Immunodeficiency Virus Neutralizing Antibodies and Methods of Use Thereof
patent-application, November 2014


Antibody responses to envelope glycoproteins in HIV-1 infection
journal, May 2015


Affinity Maturation of a Potent Family of HIV Antibodies Is Primarily Focused on Accommodating or Avoiding Glycans
journal, December 2015


Sortase-mediated ligations for the site-specific modification of proteins
journal, October 2014


cisTEM, user-friendly software for single-particle image processing
journal, March 2018


Polyvalent vaccine approaches to combat HIV-1 diversity
journal, January 2017


Early development of broadly neutralizing antibodies in HIV-1–infected infants
journal, May 2014


HIV-Specific Probabilistic Models of Protein Evolution
journal, June 2007


Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
journal, December 2017


Particle-bound Human Immunodeficiency Virus Envelope Glycoproteins and Related Compositions and Methods
patent-application, March 2006


Modified GP140 Envelope Polypeptides of HIV-1 Isolates, compositions, Stabilized Trimeric Coplexes, and Use Thereof
patent-application, February 2010


VMD: Visual molecular dynamics
journal, February 1996


Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains
journal, June 2014


Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody
journal, April 2016


Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide
journal, March 2017


B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
journal, May 2012


Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies
journal, July 2017


Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies
journal, October 2012


Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
journal, July 2011


The β20–β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions
journal, October 2017


Broad neutralization coverage of HIV by multiple highly potent antibodies
journal, September 2011


Compositions and methods for potentiated activity of biologically active molecules
patent-application, January 2010


Peptidic Antigen that Induces Antibody Recognizing Three-Dimensional Structure of HIV and Method of Synthesizing Same
patent-application, March 2012


Human cytomegalovirus RNA vaccines
patent-application, February 2018


Atomic Resolution Cryo-EM Structure of β-Galactosidase
journal, June 2018


Antibody Neutralization-Resistant Primary Isolates of Human Immunodeficiency Virus Type 1
journal, December 1998


Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop
journal, October 2016


Cytomegalovirus Antigens and Uses Thereof
patent-application, December 2017


Comparison of biosequences
journal, December 1981


A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses
journal, September 2006


EMAN2: An extensible image processing suite for electron microscopy
journal, January 2007


Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models
journal, December 2017


High throughput functional analysis of HIV-1 env genes without cloning
journal, July 2007


Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
journal, October 2018


Reconstructing a B-Cell Clonal Lineage. II. Mutation, Selection, and Affinity Maturation
journal, April 2014


CTFFIND4: Fast and accurate defocus estimation from electron micrographs
journal, November 2015


Multiple sequence alignment with hierarchical clustering
journal, November 1988


Reliability of the nanopheres-DNA immunization technology to produce polyclonal antibodies directed against human neogenic proteins
journal, June 2013


Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies
journal, September 2014


Real-space refinement in PHENIX for cryo-EM and crystallography
journal, May 2018


Viral membrane fusion
journal, July 2008


Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
journal, June 2009


Chemical Synthesis of Highly Congested gp120 V1V2 N -Glycopeptide Antigens for Potential HIV-1-Directed Vaccines
journal, August 2013


Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike
journal, July 2017


HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies
journal, March 2016


bNAber: database of broadly neutralizing HIV antibodies
journal, November 2013


HIV Transmission
journal, October 2012


Effects of inefficient cleavage of the signal sequence of HIV-1 gp 120 on its association with calnexin, folding, and intracellular transport.
journal, September 1996


Sortase-Mediated Ligation: A Gift from Gram-Positive Bacteria to Protein Engineering
journal, March 2009


RNA Containing Modified Nucleosides and Methods of Use Thereof
patent-application, November 2009


Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
journal, August 2016


MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
journal, May 2012


Evidence of efficient stop codon readthrough in four mammalian genes
journal, July 2014


Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer
journal, June 2018


DNA/NYVAC Vaccine Regimen Induces HIV-Specific CD4 and CD8 T-Cell Responses in Intestinal Mucosa
journal, October 2011


Immunoglobulin Somatic Hypermutation
journal, December 2007


A Short Segment of the HIV-1 gp120 V1/V2 Region Is a Major Determinant of Resistance to V1/V2 Neutralizing Antibodies
journal, May 2012


MolProbity : all-atom structure validation for macromolecular crystallography
journal, December 2009


Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer
journal, September 2018


Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization
journal, June 2002


Nucleic acid vaccines
patent, January 2018


A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene
journal, January 2015


Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation
journal, July 2012


Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV Env
journal, February 2015


A general method applicable to the search for similarities in the amino acid sequence of two proteins
journal, March 1970


Insights into the trimeric HIV-1 envelope glycoprotein structure
journal, February 2015


Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding
journal, November 2017


Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
journal, March 2013


Fast and sensitive multiple sequence alignments on a microcomputer
journal, April 1989


Model Building and Refinement of a Natively Glycosylated HIV-1 Env Protein by High-Resolution Cryoelectron Microscopy
journal, October 2015


Improved NYVAC-Based Vaccine Vectors
journal, November 2011


HIV Entry and Its Inhibition
journal, May 1998


RNA Containing Modified Nucleosides and Methods of Use Thereof
patent-application, August 2013


cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination
journal, February 2017


Host controls of HIV broadly neutralizing antibody development
journal, January 2017


The HIV-1 envelope glycoprotein structure: nailing down a moving target
journal, January 2017


Synthesis of Biologically Active Peptide Nucleic Acid−Peptide Conjugates by Sortase-Mediated Ligation
journal, May 2007


UCSF Chimera?A visualization system for exploratory research and analysis
journal, January 2004


HIV-1 neutralizing antibodies: understanding nature's pathways
journal, June 2013


Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
journal, October 2017